Home > Insider Trading > Filing (0001179110-15-008521)

Filing Details

Accession Number:: 0001179110-15-008521
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-22 18:07:20
Reporting Period:: 2015-05-22

Filing Date:: 2015-05-22
Accepted Time:: 2015-05-22 18:07:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579397	Charles William Shane Kovacs	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-22	60,375	$10.85	72,725	No	4	M	Direct
Common Stock	Acquisiton	2015-05-22	18,616	$27.05	91,341	No	4	M	Direct
Common Stock	Disposition	2015-05-22	64,041	$55.26	27,300	No	4	S	Direct
Common Stock	Disposition	2015-05-22	18,450	$55.93	8,850	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2015-05-22	60,375	$0.00	60,375	$10.85
Common Stock	Stock Option (Right to Buy)	Disposition	2015-05-22	18,616	$0.00	18,616	$27.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,625		2023-05-21	No	4	M	Direct
46,384		2024-01-27	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$51.00		2025-01-01	85,600	85,600	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-01-01	85,600	85,600	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.73 to $55.72 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.73 to $56.48 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014.
This option award was granted on January 28, 2014, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option award was granted on January 2, 2015, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.